151 related articles for article (PubMed ID: 9506858)
1. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas.
Selvais P; Donckier J; Buysschaert M; Maiter D
Eur J Endocrinol; 1998 Feb; 138(2):153-9. PubMed ID: 9506858
[TBL] [Abstract][Full Text] [Related]
2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
3. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?
de Herder WW; Uitterlinden P; Pieterman H; Tanghe HL; Kwekkeboom DJ; Pols HA; Singh R; van de Berge JH; Lamberts SW
Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486
[TBL] [Abstract][Full Text] [Related]
6. Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes.
Hwang YC; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
J Korean Med Sci; 2009 Feb; 24(1):46-51. PubMed ID: 19270812
[TBL] [Abstract][Full Text] [Related]
7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
8. Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.
Machado MC; Alcantara AE; Pereira AC; Cescato VA; Castro Musolino NR; de Mendonça BB; Bronstein MD; Fragoso MC
J Endocrinol Invest; 2016 Dec; 39(12):1401-1409. PubMed ID: 27363699
[TBL] [Abstract][Full Text] [Related]
9. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
[TBL] [Abstract][Full Text] [Related]
10. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
11. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
12. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
[TBL] [Abstract][Full Text] [Related]
14. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
Lankford HV; Tucker HS; Blackard WG
N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.
Blevins LS; Christy JH; Khajavi M; Tindall GT
J Clin Endocrinol Metab; 1998 Jan; 83(1):63-7. PubMed ID: 9435417
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous remission of hypercortisolism presumed due to asymptomatic tumor apoplexy in ACTH-producing pituitary macroadenoma.
Machado MC; Gadelha PS; Bronstein MD; Fragoso MC
Arq Bras Endocrinol Metabol; 2013 Aug; 57(6):486-9. PubMed ID: 24030190
[TBL] [Abstract][Full Text] [Related]
19. Patterns of ACTH response to oCRH in Cushing's disease: correlation with histological/immunocytochemical findings.
Boscaro M; Rampazzo A; Paoletta A; Scanarini M; Belluardo P; Fallo F; Sonino N
Neuroendocrinology; 1994 Sep; 60(3):237-42. PubMed ID: 7969781
[TBL] [Abstract][Full Text] [Related]
20. [Pathology and pathogenesis of pituitary corticotroph adenoma].
Trouillas J
Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
